OR WAIT null SECS
November 06, 2018
The company has rolled out the first batch of TRACON Pharmaceutical’s lead product candidate from its Singapore-based single-use bioreactor.
November 01, 2018
This new partnership provides access to Distributed Bio’s antibody discovery platforms.
he acquisition expands the company’s formulation and analytical R&D services.
October 30, 2018
The acquisition will allow Lonza to further develop technology for scalable autologous cell-therapy manufacturing.
October 29, 2018
Idifarma, a contract development and manufacturing organisation (CDMO), based in Spain, has announced the commencement of the seventh project with Palobiofarma-a Spanish biotechnology company.
October 26, 2018
AbbVie will assume full development and commercial responsibility for its collaboration with Galapagos to discover and develop new therapies to treat cystic fibrosis (CF).
October 24, 2018
AstraZeneca and Innate Pharma further expand oncology collaboration with a new multi-term agreement.
October 19, 2018
The companies will work together to advance a number of Morphic's oral integrin therapeutics for fibrosis-related indications in a deal with $100 million.
October 18, 2018
The companies will work together to develop Ionis-FB-LRx for the treatment of complement-mediated diseases, including Geographic Atrophy (GA), the advanced stage of dry age-related macular degeneration (AMD), in a deal worth $760 million.
Novartis plans to acquire Endocyte, a biopharmaceutical company, to accelerate the development of innovative radioligand technology for treating cancer.